Korea's National Institute of Health to Use Affymetrix 500K Array Set for Genome-Wide Association Studies; Collaboration to Identify Genes Associated With Diabetes, Hypertension, Asthma and Metabolic Syndrome

Teaser:

SANTA CLARA, Calif.—(BUSINESS WIRE)—March 8, 2006—Affymetrix Inc. (Nasdaq:AFFX) announced today that Korea’s National Institute of Health (NIH) and Center for Disease Control and Prevention will use the Affymetrix GeneChip(R) Human Mapping 500K Array Set for a series of groundbreaking genome-wide association studies in critical disease areas, including diabetes, hypertension, asthma and metabolic syndrome.

Source: Affymetrix, Inc.

URL:

http://www.corporate-ir.net

Information

Service

Korea's National Institute of Health to Use Affymetrix 500K Array Set for Genome-Wide Association Studies; Collaboration to Identify Genes Associated With Diabetes, Hypertension, Asthma and Metabolic Syndrome